U.S. markets closed

Zynerba Pharmaceuticals, Inc. (ZYNE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
5.64+0.22 (+4.06%)
At close: 4:00PM EDT
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
No. of Analysts4446
Avg. Estimate-0.2-0.22-0.87-1.01
Low Estimate-0.21-0.26-0.95-1.22
High Estimate-0.19-0.2-0.82-0.86
Year Ago EPS-0.78-0.31-1.9-0.87
Revenue EstimateCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
No. of Analysts4446
Avg. EstimateN/AN/AN/AN/A
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/AN/A
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History6/29/20209/29/202012/30/20203/30/2021
EPS Est.-0.45-0.43-0.33-0.25
EPS Actual-0.78-0.31-0.33-0.2
Difference-0.330.1200.05
Surprise %-73.30%27.90%0.00%20.00%
EPS TrendCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
Current Estimate-0.2-0.22-0.87-1.01
7 Days Ago-0.2-0.22-0.87-1.01
30 Days Ago-0.23-0.26-1.01-1.16
60 Days Ago-0.23-0.25-1.02-1.13
90 Days Ago-0.23-0.25-1.04-1.09
EPS RevisionsCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesZYNEIndustrySector(s)S&P 500
Current Qtr.74.40%N/AN/AN/A
Next Qtr.29.00%N/AN/AN/A
Current Year54.20%N/AN/AN/A
Next Year-16.10%N/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A